Similar Posts
Advisory Board Member Dr. Marc Shinderman Receives Paolo Picchio Award Recognizing Pioneers in the Field of Addiction Treatmen
ByAdminAdmin 10/31/2021February 9, 2004 NAMA is pleased to announce that Dr. Marc Shinderman has been recognized in Europe for his pioneering work in addiction treatment medicine. The award was presented this past December during the European Methadone Conference (Pietrosanta, Italy). One of NAMA’s international affiliates, Roberto Nardini of Sociali Gruppo SIMS helped with the presentation. The…
Comments by Andrew Byrne …Office-Based Treatment of Opiate Addiction with a Sublingual-Tabl eFormulation of Buprenorphine and Naloxon
ByAdminAdmin 08/18/2021Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…
AMTA’S Five-Year Plan for Methadone Treatment In the United States
ByAdminAdmin 05/30/2023AMTA’S Five-Year Plan for Methadone Treatment In the United States Presented at the Policy Makers Luncheon National Methadone Conference St. Louis, October 7-10, 2001 Accreditation (2001-2005) CSAT implemented new federal standards for accrediting methadone treatment programs on May 18, 2001. I submitted AMTA’s testimony in support of accreditation during my presentation to the Federal Interagency…
Basic Pharmacology
ByAdminAdmin 04/10/2023Pharmacology is the study (ology) of drugs (pharmacy). Psychopharmacology is the study of (ology) drugs (pharmacology/y) that produce their effects on the mind or brain (psycho or psyche). There are five basic classes of psycho-active drugs: 1) the opioids (i.e., heroin and methadone), 2) the stimulants (i.e., cocaine, nicotine), 3) the depressants (i.e., tranquilizers, antipsychotics,…
Tag: patient rights
ByAdminAdmin 11/08/2021DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…
Federal Register: January 17, 2001 (Volume 66, Number 11)
ByAdminAdmin 05/17/2021[Federal Register: January 17, 2001 (Volume 66, Number 11)] [Rules and Regulations] [Page 4075-4102] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17ja01-9] [[Page 4075]] ———————————————————————– Part II Department of Health and Human Services ———————————————————————– Substance Abuse and Mental Health Services Administration ———————————————————————– 21 CFR Part…